Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy

Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy

NCT00693017 ·Status: TERMINATED ·Phase: PHASE3

A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

NCT00292461 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

NCT00165828 ·Status: TERMINATED ·Phase: PHASE4

A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

NCT01546688 ·Status: TERMINATED ·Phase: PHASE4

A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures

NCT06967012 ·Status: RECRUITING ·Phase: PHASE4

Low and High Dose Zonisamide in Children as Monotherapy

NCT01127165 ·Status: COMPLETED ·Phase: PHASE4

Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation

NCT01127256 ·Status: COMPLETED ·Phase: PHASE4

Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

NCT00327717 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

NCT01630057 ·Status: COMPLETED ·Phase: PHASE4

Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures

NCT00692003 ·Status: TERMINATED ·Phase: PHASE3

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

NCT00154076 ·Status: COMPLETED ·Phase: PHASE4

Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation

NCT00298818 ·Status: COMPLETED

ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs

NCT00659958 ·Status: COMPLETED ·Phase: PHASE4

A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)

NCT01830868 ·Status: COMPLETED

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

NCT06534502 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate

NCT00713622 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

NCT00866775 ·Status: COMPLETED ·Phase: PHASE3

A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

NCT00231556 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

NCT01431963 ·Status: COMPLETED ·Phase: PHASE3

Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy

NCT06374966 ·Status: NOT_YET_RECRUITING

Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures

NCT02484001 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

NCT05159908 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy

NCT00957047 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures

NCT01162460 ·Status: COMPLETED ·Phase: PHASE3

A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)

NCT03198949 ·Status: COMPLETED ·Phase: PHASE2